Sinovac Delivers 80,000 Vaccine Doses to Earthquake Victims

Sinovac Biotech Ltd. (SVA) sold 80,000 doses of Bilive, the company’s combined hepatitis A and B vaccine, to the Municipal Health Bureau and Municipal Center for Disease Control. The vaccine will be freely distributed to inoculate children in the Longnan, Gansu Province area, which was hit by the earthquake last month. Bilive is distributed in prefilled syringes.

The order was received on June 2 and delivered to Lanzhou, Gansu on June 3, together with 80,000 vaccine inoculation instructions and two million copies of infectious disease prevention guidebooks. The printed material was coordinated by the CDC in Beijing. Sinovac also sent its disease control advisory group to oversee the operation in cooperation with the local CDC.

In the immediate aftermath of the earthquake, Sinovac donated 50,000 doses of Healive, its inactivated hepatitis A vaccine, to the earthquake victims, 10,000 doses of which went to Gansu province. On May 22, 2008, the Ministry of Health purchased approximately 20 million RMB ($2.9 million) of Healive. 30,000 doses from this order were delivered to the Gansu province.

Disclosure: none.